can someone tell me if prp is effective for you
    1/7/2022

    New to Spironolactone? There is a guide in the encyclopedia. Read the guide →
    At a glance
    In this question or advice post, the primary subjects mentioned are
    💊 spironolactone (oral)
    💊 krimson (oral)
    the tone is 😐 neutral.

    Other terms

    21-year-old female experiencing hair loss and visible scalp seeks advice on PRP effectiveness. Currently taking spironolactone and krimson for high androgens, unsure if PRP can be done with these medications.
    View this post in the Community →

    Similar Community Posts Join

    6 / 6 results

    Related Research

    6 / 6 results

      research Female pattern hair loss—An update

      12 citations , January 2020 in “Indian Dermatology Online Journal”
      This article discusses the causes, diagnosis, and treatment options for female pattern hair loss, emphasizing the role of topical minoxidil as a primary treatment, but provides no new clinical results.
      Development of a Non-Parametric Population Pharmacokinetics Model and Bayesian Estimator for Tacrolimus in Tunisian Renal Transplant Patients

      research Poster Abstracts

      March 2017 in “Fundamental & Clinical Pharmacology”
      This case study reported an improvement in lower limb edema for a patient with type 2 diabetes mellitus after starting dulaglutide treatment, suggesting a potential role of the drug in sodium retention disorders.
      Interventions for Female Pattern Hair Loss

      research Interventions for female pattern hair loss

      21 citations , May 2016 in “The Cochrane library”
      This review found that while topical minoxidil is effective for treating female pattern hair loss, finasteride showed no more effectiveness than placebo, and low-level laser therapy increased hair count but with inconsistent results.
      Pharmacological Treatment of Alopecia

      research Pharmacological Treatment of Alopecia

      1 citations , October 2018 in “InTech eBooks”
      This chapter reviews current and emerging pharmacological treatments for alopecia, noting that the FDA's classification of alopecia as a cosmetic disease has limited drug development and led to off-label use of potentially dangerous compounds.